August 25, 2023 Comments Off on New patent for Alkermes Inc drug LYBALVI Posted in: Patent Added Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatentWa…
August 25, 2023 Comments Off on New patent for Takeda Pharms drug TRINTELLIX Posted in: Patent Added Annual Drug Patent Expirations for TRINTELLIX Trintellix is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from three suppliers. There are ten…
The post New patent for Takeda Pharms drug TRINTELLIX appeared first on Dr…
